Immunology-Focused Coultreon Adds $125M for Pills That Pack the Punch of Injectable Biologics
Coultreon Biopharma’s lead drug candidate, acquired from Galapagos, is a small molecule designed to selectively inhibit a novel immunology goal ...
Coultreon Biopharma’s lead drug candidate, acquired from Galapagos, is a small molecule designed to selectively inhibit a novel immunology goal ...
Startup Pinnacle Medicines is growing peptide medication with the identical efficacy as biologic medicines and the dosing comfort of oral ...
WASHINGTON — Well being secretary Robert F. Kennedy Jr. introduced two new members of his handpicked panel of vaccine advisers ...
Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program ...
AbbVie wasn’t part of the first wave of cell therapies developed for cancer, but it is positioning itself to contend ...
The US Centers for Disease Control and Prevention (CDC) reported 17 more measles cases today in its weekly update, bringing ...
Serve You Rx, a pharmacy benefit manager, has added two recently approved biosimilars to Stelara to its formulary, the company ...
Amazon Pharmacy announced two major updates on Tuesday — an expansion of PillPack to Medicare Part D and a new ...
Regeneron Pharmaceuticals, a company that has been analyzing genetic data as part of its drug research for more than a ...
Tech giant Microsoft announced it is adding Elon Musk's AI startup xAI's Grok 3 to its Azure platform. Grok 3 ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.